Brain Edema - Pipeline Review, H2, Pharmaceutical 2016
"Brain
Edema - Pipeline Review, H2 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Markets Direct's latest Pharmaceutical and Healthcare disease
pipeline guide Brain Edema - Pipeline Review, H2 2016, provides an
overview of the Brain Edema (Central Nervous System) pipeline
landscape.
Brain
swelling is enlargement of the brain due to excessive fluid
collection in the chambers, or ventricles, of the brain or the
accumulation of fluid within the brain tissue itself. Cause of brain
swelling includes traumatic brain injury (tbi), ischemic stroke,
hemorrhages, tumors and infections (toxoplasmosis, meningitis,
subdural empyema). Symptoms include headache, neck pain or stiffness,
nausea or vomiting, dizziness, irregular breathing, vision loss or
changes, memory loss, inability to walk, difficulty speaking, stupor,
seizures and loss of consciousness.
Report
Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Brain Edema - Pipeline Review, H2 2016, provides comprehensive
information on the therapeutics under development for Brain Edema
(Central Nervous System), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
The
Brain Edema (Central Nervous System) pipeline guide also reviews of
key players involved in therapeutic development for Brain Edema and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase I,
Preclinical and Discovery stages are 1, 1 and 1 respectively.
Scope
-
The pipeline guide provides a snapshot of the global therapeutic
landscape of Brain Edema (Central Nervous System).
-
The pipeline guide reviews pipeline therapeutics for Brain Edema
(Central Nervous System) by companies and universities/research
institutes based on information derived from company and
industry-specific sources.
-
The pipeline guide covers pipeline products based on several stages
of development ranging from pre-registration till discovery and
undisclosed stages.
-
The pipeline guide features descriptive drug profiles for the
pipeline products which comprise, product description, descriptive
licensing and collaboration details, R&D brief, MoA & other
developmental activities.
-
The pipeline guide reviews key companies involved in Brain Edema
(Central Nervous System) therapeutics and enlists all their major and
minor projects.
Reasons
to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage.
-
Find and recognize significant and varied types of therapeutics under
development for Brain Edema (Central Nervous System).
-
Classify potential new clients or partners in the target demographic.
-
Develop tactical initiatives by understanding the focus areas of
leading companies.
-
Plan mergers and acquisitions meritoriously by identifying key
players and its most promising pipeline therapeutics.
Comments
Post a Comment